Cargando…
OR32-02 Immune Checkpoint Inhibitor-Induced Hypophysitis Is Associated with Improved Overall Survival in Cancer Patients
Context: Immune checkpoint inhibitors (ICIs) are monoclonal antibodies against checkpoints namely CTLA-4, PD-1 and PD-L1. These can cause pituitary dysfunction due to hypophysitis in addition to other endocrinopathies. While the prevalence and course of hypophysitis have been described extensively,...
Autores principales: | Kotwal, Anupam, Rouleau, Samuel G, Kottschade, Lisa, Ryder, Mabel M, Kudva, Yogish C, Markovic, Svetomir, Erickson, Dana Z |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208570/ http://dx.doi.org/10.1210/jendso/bvaa046.869 |
Ejemplares similares
-
Characterizing Immune Checkpoint Inhibitor-Induced Hypophysitis and Obstacles in Diagnosis
por: Johnson, Jake, et al.
Publicado: (2021) -
Stuck at the Checkpoint: Pembrolizumab Induced Hypophysitis With ‘Normal’ Cosyntropin Response
por: Kasiri, Elnaz, et al.
Publicado: (2021) -
SUN-298 Spectrum of Imaging in Immune Checkpoint Inhibitor Induced Hypophysitis
por: Quandt, Zoe, et al.
Publicado: (2020) -
Idiopathic Hypophysitis
por: Amjed, Hafsa, et al.
Publicado: (2021) -
OR32-06 Opportunistic Assessment of Pituitary Gland with Routine MRI and PET/CT Can Guide in Earlier and Increased Identification of Hypophysitis in Patients Treated with Combination Checkpoint Inhibitors
por: Galligan, Anna, et al.
Publicado: (2020)